Boosting NAD preferentially blunts Th17 inflammation via arginine biosynthesis and redox control in healthy and psoriasis subjects. (2023)

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.xcrm.2023.101157

PubMed Identifier: 37586364

Publication URI: http://europepmc.org/abstract/MED/37586364

Type: Journal Article/Review

Volume: 4

Parent Publication: Cell reports. Medicine

Issue: 9

ISSN: 2666-3791